NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 283 filers reported holding NATERA INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,388 | -9.1% | 7,150 | -0.1% | 0.00% | 0.0% |
| Q2 2023 | $348,114 | -30.9% | 7,154 | -21.1% | 0.00% | -40.0% |
| Q1 2023 | $503,677 | +28.6% | 9,072 | -6.9% | 0.01% | +66.7% |
| Q4 2022 | $391,537 | -99.9% | 9,747 | -44.4% | 0.00% | -25.0% |
| Q3 2022 | $384,384,000 | +168489.5% | 17,518 | +172.4% | 0.00% | +100.0% |
| Q2 2022 | $228,000 | -5.8% | 6,432 | +8.2% | 0.00% | -33.3% |
| Q1 2022 | $242,000 | -58.0% | 5,942 | -3.6% | 0.00% | -50.0% |
| Q4 2021 | $576,000 | -36.5% | 6,166 | -24.2% | 0.01% | -33.3% |
| Q3 2021 | $907,000 | -1.4% | 8,136 | +0.4% | 0.01% | -10.0% |
| Q2 2021 | $920,000 | +5.5% | 8,103 | -5.6% | 0.01% | -9.1% |
| Q1 2021 | $872,000 | +7.3% | 8,583 | +4.4% | 0.01% | +22.2% |
| Q4 2020 | $813,000 | -99.8% | 8,221 | +8039.6% | 0.01% | 0.0% |
| Q3 2020 | $504,000,000 | – | 101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |